Protein Symbol | Approved Name | Docking Scores |
Similarity Score |
Best Match | ||
---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | ||||
5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -9.27 | -8.94 | -8.39 | 33.46% | CHEMBL1632218 |
5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -9.56 | -8.18 | N/A | 39.76% | CHEMBL3899099 |
5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -8.99 | -9.00 | -8.90 | 39.76% | CHEMBL3899099 |
5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -9.11 | -9.36 | N/A | 39.93% | CHEMBL4098357 |
AA1R_HUMAN | adenosine A1 receptor | -8.56 | -8.39 | -7.22 | 32.09% | CHEMBL3234963 |
AA2AR_HUMAN | adenosine A2a receptor | -8.71 | -8.70 | -8.29 | 36.13% | CHEMBL601413 |
ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -10.10 | -9.40 | -6.24 | 42.03% | CHEMBL3343928 |
ACE_HUMAN | angiotensin I converting enzyme | -8.70 | -8.25 | -6.32 | 36.84% | CHEMBL148616 |
ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -6.87 | N/A | N/A | 29.51% | CHEMBL386114 |
ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -5.55 | -7.51 | -5.06 | N/A | N/A |
ACM1_HUMAN | cholinergic receptor muscarinic 1 | -8.40 | -0.40 | N/A | 36.59% | CHEMBL2206597 |
ACM4_HUMAN | cholinergic receptor muscarinic 4 | -8.58 | -7.18 | N/A | 36.77% | CHEMBL2313397 |
ADRB2_HUMAN | adrenoceptor beta 2 | -7.39 | -8.62 | -9.26 | 37.98% | CHEMBL419085 |
AGTR2_HUMAN | angiotensin II receptor type 2 | -8.97 | -8.87 | -8.61 | 37.68% | CHEMBL339544 |
ALDR_HUMAN | aldo-keto reductase family 1 member B | -8.69 | -8.00 | -8.83 | 41.36% | CHEMBL20685 |
AMPN_HUMAN | alanyl aminopeptidase, membrane | -8.02 | -8.40 | -8.16 | 38.41% | CHEMBL1077591 |
AOFA_HUMAN | monoamine oxidase A | -9.82 | -8.94 | -9.45 | 28.19% | CHEMBL3310020 |
AOFB_HUMAN | monoamine oxidase B | -9.94 | -9.20 | -8.37 | 29.43% | CHEMBL3093174 |
BACE1_HUMAN | beta-secretase 1 | -6.67 | -7.36 | -8.01 | 54.89% | CHEMBL3639931 |
CAH2_HUMAN | carbonic anhydrase 2 | -7.65 | -7.85 | -7.44 | 36.80% | CHEMBL50045 |
CASP1_HUMAN | caspase 1 | -6.48 | -7.04 | -6.51 | 35.28% | CHEMBL181768 |
CDK5_HUMAN | cyclin dependent kinase 5 | -7.50 | -8.09 | -7.31 | 31.72% | CHEMBL1989043 |
CHLE_HUMAN | butyrylcholinesterase | -9.25 | -9.33 | -9.50 | 40.65% | CHEMBL4078849 |
CNR1_HUMAN | cannabinoid receptor 1 | -7.63 | -9.16 | -10.15 | 46.59% | CHEMBL3985937 |
CNR2_HUMAN | cannabinoid receptor 2 | -9.61 | -9.96 | N/A | 53.60% | CHEMBL3939093 |
COLI_HUMAN | proopiomelanocortin | -7.80 | -7.91 | -8.15 | N/A | N/A |
COMT_HUMAN | catechol-O-methyltransferase | -5.78 | -6.33 | -5.94 | 31.15% | CHEMBL3819488 |
CRP_HUMAN | C-reactive protein | -5.70 | -5.84 | N/A | N/A | N/A |
CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | -2.86 | N/A | N/A | 41.03% | CHEMBL401893 |
CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -8.59 | -6.99 | -7.97 | 40.56% | CHEMBL3627794 |
DRD2_HUMAN | dopamine receptor D2 | -7.85 | N/A | N/A | 54.44% | CHEMBL2152746 |
DRD3_HUMAN | dopamine receptor D3 | -8.50 | N/A | N/A | 54.44% | CHEMBL2152746 |
DRD4_HUMAN | dopamine receptor D4 | -9.58 | -10.00 | N/A | 38.93% | CHEMBL301265 |
EDN1_HUMAN | endothelin 1 | -8.75 | N/A | N/A | N/A | N/A |
ESR1_HUMAN | estrogen receptor 1 | -7.51 | -7.78 | -7.77 | 34.73% | CHEMBL434502 |
FABP5_HUMAN | fatty acid binding protein 5 | -8.06 | -6.02 | -5.64 | 29.64% | CHEMBL3890665 |
FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -8.65 | N/A | N/A | 32.63% | CHEMBL3622137 |
GLRA3_HUMAN | glycine receptor alpha 3 | -8.16 | -8.72 | -8.50 | 26.48% | CHEMBL4070615 |
GLRA3_HUMAN | glycine receptor alpha 3 | -8.20 | N/A | N/A | 26.48% | CHEMBL4070615 |
GRM5_HUMAN | glutamate metabotropic receptor 5 | -6.36 | -5.91 | -5.74 | 43.06% | CHEMBL3672914 |
HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -7.98 | -7.54 | -7.83 | 32.58% | CHEMBL3650217 |
HRH1_HUMAN | histamine receptor H1 | -6.51 | N/A | N/A | 39.76% | CHEMBL3899099 |
HYES_HUMAN | epoxide hydrolase 2 | -7.94 | -8.64 | -8.54 | 30.77% | CHEMBL589133 |
IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -8.55 | N/A | N/A | 31.11% | CHEMBL492755 |
MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -8.81 | -8.70 | N/A | 47.37% | CHEMBL4077753 |
MIF_HUMAN | macrophage migration inhibitory factor | -6.90 | -6.66 | -6.16 | 22.03% | CHEMBL554271 |
MK01_HUMAN | mitogen-activated protein kinase 1 | -7.70 | -7.54 | -8.05 | 41.67% | CHEMBL3919801 |
MK03_HUMAN | mitogen-activated protein kinase 3 | -8.30 | -9.12 | -8.38 | 30.52% | CHEMBL213618 |
MTOR_HUMAN | mechanistic target of rapamycin kinase | -8.90 | -9.35 | -9.76 | 36.31% | CHEMBL2334767 |
NEP_HUMAN | membrane metalloendopeptidase | -7.49 | -6.96 | -7.91 | 31.34% | CHEMBL198316 |
NK1R_HUMAN | tachykinin receptor 1 | -8.05 | -8.62 | -8.49 | 39.41% | CHEMBL1766208 |
NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -8.66 | -7.57 | -8.17 | 18.73% | CHEMBL2333945 |
NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -9.43 | -9.17 | -8.62 | 25.41% | CHEMBL444384 |
NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -8.51 | -8.39 | -8.17 | 34.53% | CHEMBL354003 |
NOS1_HUMAN | nitric oxide synthase 1 | -8.20 | -8.17 | -7.89 | 34.04% | CHEMBL489724 |
NOS2_HUMAN | nitric oxide synthase 2 | -8.16 | -8.01 | -1.68 | 34.70% | CHEMBL491723 |
NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -8.35 | -8.57 | -8.47 | 37.16% | CHEMBL3666420 |
OPRD_HUMAN | opioid receptor delta 1 | -7.62 | -6.67 | -7.73 | 40.00% | CHEMBL605735 |
OPRK_HUMAN | opioid receptor kappa 1 | -9.52 | -8.61 | -8.89 | 41.74% | CHEMBL1412078 |
OPRM_MOUSE | Mu-type opioid receptor | -8.45 | -8.09 | N/A | 36.86% | CHEMBL316863 |
OPRX_HUMAN | opioid related nociceptin receptor 1 | -7.79 | -8.12 | -8.03 | 38.25% | CHEMBL511373 |
P2RX3_HUMAN | purinergic receptor P2X 3 | -5.73 | -5.71 | -5.97 | 39.46% | CHEMBL3679841 |
P2Y12_HUMAN | purinergic receptor P2Y12 | -8.24 | -7.37 | -9.34 | 34.01% | CHEMBL3322647 |
PAR1_HUMAN | coagulation factor II thrombin receptor | -7.20 | N/A | N/A | 37.17% | CHEMBL68372 |
PDE4B_HUMAN | phosphodiesterase 4B | -8.06 | -7.93 | -8.35 | 41.39% | CHEMBL3288016 |
PDE5A_HUMAN | phosphodiesterase 5A | -7.87 | -9.27 | -8.06 | 43.12% | CHEMBL1650876 |
PERM_HUMAN | myeloperoxidase | -7.92 | -8.09 | -7.97 | 27.00% | CHEMBL86 |
PGH1_SHEEP | Prostaglandin G/H synthase 1 | -7.60 | -7.34 | -5.95 | 32.30% | CHEMBL9191 |
PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | -1.70 | -8.33 | -7.09 | 38.57% | CHEMBL27875 |
PPAP_HUMAN | acid phosphatase 3 | -7.40 | N/A | N/A | 14.73% | CHEMBL507996 |
PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -8.53 | -8.72 | -8.07 | 36.28% | CHEMBL1778840 |
PRGR_HUMAN | progesterone receptor | 0.93 | 2.03 | -8.02 | 38.71% | CHEMBL551782 |
PTGES_HUMAN | prostaglandin E synthase | -7.67 | N/A | N/A | 41.59% | CHEMBL3660831 |
SC6A4_HUMAN | solute carrier family 6 member 4 | -9.56 | -9.34 | -9.50 | 43.30% | CHEMBL3128180 |
SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -7.89 | N/A | N/A | 40.00% | CHEMBL3960184 |
TLR4_HUMAN | toll like receptor 4 | -8.10 | -7.52 | -7.76 | 20.07% | CHEMBL1223751 |
TNFA_HUMAN | tumor necrosis factor | -7.54 | N/A | N/A | 35.31% | CHEMBL3806135 |
TRBM_HUMAN | thrombomodulin | -8.55 | -7.23 | N/A | N/A | N/A |
TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -7.64 | -6.38 | N/A | N/A | N/A |
TRPM8_FICAL | Uncharacterized protein | -9.22 | N/A | N/A | N/A | N/A |
TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -8.81 | N/A | N/A | 34.93% | CHEMBL438345 |
TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -7.23 | -6.87 | N/A | N/A | N/A |
TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -7.35 | -7.20 | N/A | 34.58% | CHEMBL3696446 |
TRXR1_HUMAN | thioredoxin reductase 1 | -7.93 | -7.36 | -6.38 | N/A | N/A |
TRY1_HUMAN | serine protease 1 | -7.00 | N/A | N/A | 53.76% | CHEMBL169291 |